30th Nov 2007 12:10
Ark Therapeutics Group PLC30 November 2007 30 November 2007 Ark Therapeutics Group plc Voting Rights and Capital In accordance with the FSA's Disclosure and Transparency Rules, Ark TherapeuticsGroup plc (LSE: AKT) ("Ark" or the "Company") confirms that as at the date ofthis announcement the Company's issued share capital consists of 201,938,969ordinary shares with voting rights. This figure may be used by shareholders as the denominator for the calculationsby which they will determine if they are required to notify their interest in,or a change to the interest in, Ark under the FSA's Disclosure and TransparencyRules. - Ends - This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
PVG.L